Detalles de la búsqueda
1.
Development and Evaluation of Dissolving Microarray Patches for Co-administered and Repeated Intradermal Delivery of Long-acting Rilpivirine and Cabotegravir Nanosuspensions for Paediatric HIV Antiretroviral Therapy.
Pharm Res
; 40(7): 1673-1696, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36224503
2.
A Bilayer Microarray Patch (MAP) for HIV Pre-Exposure Prophylaxis: The Role of MAP Designs and Formulation Composition in Enhancing Long-Acting Drug Delivery.
Pharmaceutics
; 16(1)2024 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38276512
3.
Accelerating the development of vaccine microarray patches for epidemic response and equitable immunization coverage requires investment in microarray patch manufacturing facilities.
Expert Opin Drug Deliv
; 20(3): 315-322, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36649573
4.
Assessing the risk of a clinically significant infection from a Microneedle Array Patch (MAP) product.
J Control Release
; 361: 236-245, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37437849
5.
Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling.
Eur J Drug Metab Pharmacokinet
; 47(6): 855-868, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36178586
6.
Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges.
Front Public Health
; 10: 809675, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35309224
7.
Correction to: Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling.
Eur J Drug Metab Pharmacokinet
; 48(1): 119, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36517732
Resultados
1 -
7
de 7
1
Próxima >
>>